⌘K
Loading ticker…
Syndax Pharmaceuticals, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Syndax Pharmaceuticals, Inc. (SNDX) has a 3-month relative strength percentile of 22 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.6%, relative volume 2.23×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
22 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
SNDX is in a stage 3 topping pattern, week 2. Currently in a 58-day base; basing ADR 4.6% (broad 5.0%). VCP detected: 3 contractions. RS line below base-start high. Distance from 50d / 200d: 6.4% / 8.8%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
SNDX is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $64M notional. Top 3 carry $168M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $64M |
| XBIState Street SPDR S&P Biotech ETF | 0.74% | $55M |
| IWMiShares Russell 2000 ETF | 0.07% | $49M |
| VXFVanguard Extended Market ETF | 0.03% | $23M |
| IWOiShares Russell 2000 Growth ETF | 0.13% | $15M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $3M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SNDX Jan avg: 2.86% median: 1.93% win: 50% σ: 8.56% n: 4 2022-04-12 → 2026-05-29 | SNDX Feb avg: 5.00% median: 8.63% win: 75% σ: 11.53% n: 4 2022-04-12 → 2026-05-29 | SNDX Mar avg: -7.25% median: -7.58% win: 50% σ: 14.01% n: 4 2022-04-12 → 2026-05-29 | SNDX Apr avg: -2.46% median: -5.31% win: 20% σ: 10.37% n: 5 2022-04-12 → 2026-05-29 | SNDX May avg: -9.47% median: -8.59% win: 0% σ: 9.55% n: 5 2022-04-12 → 2026-05-29 | SNDX Jun avg: 4.20% median: 5.67% win: 75% σ: 11.48% n: 4 2022-04-12 → 2026-05-29 (current) | SNDX Jul avg: 6.06% median: 5.90% win: 100% σ: 3.56% n: 4 2022-04-12 → 2026-05-29 | SNDX Aug avg: 14.47% median: 3.22% win: 50% σ: 35.84% n: 4 2022-04-12 → 2026-05-29 | SNDX Sep avg: -7.97% median: -6.06% win: 25% σ: 9.78% n: 4 2022-04-12 → 2026-05-29 | SNDX Oct avg: -5.12% median: -3.74% win: 0% σ: 4.02% n: 4 2022-04-12 → 2026-05-29 | SNDX Nov avg: 13.97% median: 11.29% win: 75% σ: 23.76% n: 4 2022-04-12 → 2026-05-29 | SNDX Dec avg: 5.28% median: 6.11% win: 75% σ: 20.75% n: 4 2022-04-12 → 2026-05-29 |